Prominin 2 decreases cisplatin sensitivity in non-small cell lung cancer and is modulated by CTCC binding factor

BACKGROUND: Non-small cell lung cancer (NSCLC) is the major pathological type of lung cancer and accounts for the majority of lung cancer-related deaths worldwide. We investigated the molecular mechanism of prominin 2 (PROM2) involved in cisplatin resistance in NSCLC. PATIENTS AND METHODS: The GEO d...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Jiyang, Shu, Dejun, Fang, Zhimin, Yang, Gaolan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476904/
https://www.ncbi.nlm.nih.gov/pubmed/37665741
http://dx.doi.org/10.2478/raon-2023-0033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476904/
https://www.ncbi.nlm.nih.gov/pubmed/37665741
http://dx.doi.org/10.2478/raon-2023-0033

Ejemplares similares